Literature DB >> 1856486

Characteristics of experimental Candida albicans infection of the central nervous system in rabbits.

H S Jafari1, X Sáez-Llorens, E Grimprel, J C Argyle, K D Olsen, G H McCracken.   

Abstract

Different concentrations (10(7), 10(5), 10(3) cfu/ml) of Candida albicans were injected intracisternally in rabbits. The highest inoculum was fatal within 14 h in all animals. In recipients of 10(5) and 10(3) cfu/ml inocula, the mean +/- SD peak cerebrospinal fluid (CSF) tumor necrosis factor-alpha (TNF alpha) concentrations were 1.6 +/- 2.42 and 0.3 +/- 0.59 ng/ml, respectively, at 6 h; the mean +/- SD CSF leukocyte and protein concentrations were 6291 +/- 6515 and 453 +/- 674 cells/mm3 (at 24 h) and 118 +/- 90 and 109 +/- 122 mg/dl (at 12 and 24 h), respectively. At 6-10 days after inoculation, a second peak of TNF alpha activity was accompanied by increased CSF inflammation. Mortality in the 10(5) and 10(3) cfu/ml inoculum groups was 56% and 22%, respectively. Fatal infection was associated with higher second CSF peak TNF alpha and leukocyte concentrations and a larger proportion of culture-positive CSF samples. Histopathology revealed hyphal invasion, vasculitis, abscesses, and acute and chronic inflammatory infiltration of meninges and brain parenchyma. This model can be useful for evaluation of the pathogenesis and therapy of central nervous system fungal infections.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1856486     DOI: 10.1093/infdis/164.2.389

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  7 in total

1.  Candida albicans stimulates cytokine production and leukocyte adhesion molecule expression by endothelial cells.

Authors:  S G Filler; A S Pfunder; B J Spellberg; J P Spellberg; J E Edwards
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

2.  Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits.

Authors:  R Petraitiene; V Petraitis; A H Groll; M Candelario; T Sein; A Bell; C A Lyman; C L McMillian; J Bacher; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

3.  Adhesion of Candida albicans to brain tissue of Macaca mulata in an ex vivo assay.

Authors:  F J Denaro; J L López-Ribot; W L Chaffin
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

Review 4.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

5.  The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates.

Authors:  William W Hope; Diana Mickiene; Vidmantas Petraitis; Ruta Petraitiene; Amy M Kelaher; Joanna E Hughes; Margaret P Cotton; John Bacher; James J Keirns; Donald Buell; Gloria Heresi; Daniel K Benjamin; Andreas H Groll; George L Drusano; Thomas J Walsh
Journal:  J Infect Dis       Date:  2008-01-01       Impact factor: 5.226

6.  Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.

Authors:  H S Jafari; X Sáez-Llorens; C Severien; F Parras; I Friedland; S Rinderknecht; S Ehrett; K D Olsen; C Abramowsky; G H McCracken
Journal:  Antimicrob Agents Chemother       Date:  1994-01       Impact factor: 5.191

Review 7.  Animal models: an important tool in mycology.

Authors:  Javier Capilla; Karl V Clemons; David A Stevens
Journal:  Med Mycol       Date:  2007-12       Impact factor: 4.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.